Q3 2025 saw strong financial and operational performance, with net income up 82% and cash flow to shareholders up 35% year-over-year. Growth was driven by healthcare and digital segments, efficiency gains, and a disciplined capital allocation approach.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.